CVS
CVS Health Corporation [CVS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CVS Stock Summary
Top CVS Correlated Resources
CVS
Top 10 Correlated ETFs
CVS
Top 10 Correlated Stocks
CVS
In the News
CVS Financial details
CVS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 197.37 | 205.28 | 221.46 | 245.78 | 278.42 | |
| Net income per share | 5.1 | 5.48 | 6.07 | 3.29 | 6.49 | |
| Operating cash flow per share | 9.88 | 12.12 | 13.85 | 12.33 | 10.45 | |
| Free cash flow per share | 7.99 | 10.26 | 11.94 | 10.25 | 8.09 | |
| Cash per share | 6.19 | 8.29 | 9.5 | 11.98 | 8.91 | |
| Book value per share | 49.09 | 53.01 | 56.92 | 54.13 | 59.5 | |
| Tangible book value per share | -37.43 | -31.32 | -24.84 | -24.08 | -34.14 | |
| Share holders equity per share | 49.09 | 53.01 | 56.92 | 54.13 | 59.5 | |
| Interest debt per share | 70.74 | 67.19 | 59.52 | 55.65 | 63.85 | |
| Market cap | 96.65B | 89.4B | 136.07B | 122.27B | 101.46B | |
| Enterprise value | 179.97B | 166.59B | 202.66B | 180.05B | 172.65B | |
| P/E ratio | 14.57 | 12.45 | 17.01 | 28.36 | 12.16 | |
| Price to sales ratio | 0.38 | 0.33 | 0.47 | 0.38 | 0.28 | |
| POCF ratio | 7.52 | 5.64 | 7.45 | 7.56 | 7.56 | |
| PFCF ratio | 9.3 | 6.66 | 8.64 | 9.09 | 9.76 | |
| P/B Ratio | 1.51 | 1.29 | 1.81 | 1.72 | 1.33 | |
| PTB ratio | 1.51 | 1.29 | 1.81 | 1.72 | 1.33 | |
| EV to sales | 0.7 | 0.62 | 0.69 | 0.56 | 0.48 | |
| Enterprise value over EBITDA | 10.92 | 8.98 | 10.3 | 8.78 | 9.06 | |
| EV to operating cash flow | 14.01 | 10.5 | 11.1 | 11.13 | 12.86 | |
| EV to free cash flow | 17.32 | 12.41 | 12.87 | 13.39 | 16.61 | |
| Earnings yield | 0.07 | 0.08 | 0.06 | 0.04 | 0.08 | |
| Free cash flow yield | 0.11 | 0.15 | 0.12 | 0.11 | 0.1 | |
| Debt to equity | 1.39 | 1.23 | 1.01 | 1 | 1.04 | |
| Debt to assets | 0.4 | 0.37 | 0.33 | 0.31 | 0.32 | |
| Net debt to EBITDA | 5.06 | 4.16 | 3.38 | 2.82 | 3.74 | |
| Current ratio | 0.94 | 0.91 | 0.88 | 0.94 | 0.86 | |
| Interest coverage | 3.95 | 4.79 | 5.27 | 7.11 | 5.17 | |
| Income quality | 1.94 | 2.21 | 2.31 | 3.88 | 1.6 | |
| Dividend Yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | |
| Payout ratio | 0.39 | 0.37 | 0.33 | 0.67 | 0.38 | |
| Sales general and administrative to revenue | 0.13 | 0.13 | 0.12 | 0.12 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.51 | 0.48 | 0.46 | 0.45 | 0.48 | |
| Capex to operating cash flow | -0.19 | -0.15 | -0.14 | -0.17 | -0.23 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.56 | -0.55 | -0.56 | -0.64 | -0.69 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 75.05 | 80.88 | 88.14 | 63.26 | 93.24 | |
| ROIC | 0.05 | 0.06 | 0.06 | 0.08 | 0.06 | |
| Return on tangible assets | 0.06 | 0.06 | 0.06 | 0.03 | 0.06 | |
| Graham Net | -97.43 | -95.19 | -89.38 | -84.78 | -98.21 | |
| Working capital | -3B | -5.65B | -7.8B | -4.05B | -11.33B | |
| Tangible asset value | -48.7B | -40.99B | -32.77B | -31.59B | -43.87B | |
| Net current asset value | -107.98B | -104.65B | -97.61B | -91.28B | -105.23B | |
| Invested capital | 1.39 | 1.23 | 1.01 | 1 | 1.04 | |
| Average receivables | 18.62B | 20.68B | 23.09B | 25.85B | 31.25B | |
| Average payables | 9.71B | 10.82B | 11.84B | 13.69B | 14.87B | |
| Average inventory | 16.98B | 18.01B | 18.13B | 18.43B | 18.56B | |
| Days sales outstanding | 27.89 | 29.53 | 30.53 | 30.87 | 35.94 | |
| Days payables outstanding | 18.13 | 18.51 | 19.07 | 20.2 | 17.92 | |
| Days of inventory on hand | 30.26 | 30.73 | 27 | 25.98 | 21.69 | |
| Receivables turnover | 13.09 | 12.36 | 11.96 | 11.82 | 10.16 | |
| Payables turnover | 20.13 | 19.72 | 19.14 | 18.07 | 20.36 | |
| Inventory turnover | 12.06 | 11.88 | 13.52 | 14.05 | 16.83 | |
| ROE | 0.1 | 0.1 | 0.11 | 0.06 | 0.11 | |
| Capex per share | -1.89 | -1.86 | -1.91 | -2.08 | -2.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 64 | 66.47 | 69.31 | 69.75 | 72.84 | |
| Net income per share | 1.76 | 1.66 | 1.48 | 1.76 | 1.59 | |
| Operating cash flow per share | -1.49 | 5.8 | 4.6 | 2.11 | -2.05 | |
| Free cash flow per share | -2.02 | 5.03 | 4.14 | 1.69 | -2.75 | |
| Cash per share | 12 | 13.81 | 13.16 | 12.58 | 8.89 | |
| Book value per share | 54.21 | 55.64 | 56.68 | 57.76 | 59.36 | |
| Tangible book value per share | -24.11 | -30.28 | -37.71 | -36.03 | -34.06 | |
| Share holders equity per share | 54.21 | 55.64 | 56.68 | 57.76 | 59.36 | |
| Interest debt per share | 54.42 | 60.07 | 64.55 | 62.77 | 62.17 | |
| Market cap | 122.08B | 95.34B | 88.69B | 89.86B | 101.7B | |
| Enterprise value | 179.87B | 157.2B | 157.02B | 156.91B | 172.89B | |
| P/E ratio | 13.26 | 11.16 | 11.66 | 9.94 | 12.43 | |
| Price to sales ratio | 1.46 | 1.12 | 1 | 1 | 1.08 | |
| POCF ratio | -62.54 | 12.82 | 15.01 | 33.08 | -38.58 | |
| PFCF ratio | -46.24 | 14.77 | 16.68 | 41.39 | -28.67 | |
| P/B Ratio | 1.72 | 1.34 | 1.22 | 1.21 | 1.33 | |
| PTB ratio | 1.72 | 1.34 | 1.22 | 1.21 | 1.33 | |
| EV to sales | 2.15 | 1.84 | 1.77 | 1.75 | 1.84 | |
| Enterprise value over EBITDA | 47.68 | 32.63 | 32.34 | 42.52 | 38.17 | |
| EV to operating cash flow | -92.14 | 21.13 | 26.58 | 57.77 | -65.59 | |
| EV to free cash flow | -68.13 | 24.36 | 29.53 | 72.28 | -48.74 | |
| Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Free cash flow yield | -0.02 | 0.07 | 0.06 | 0.02 | -0.03 | |
| Debt to equity | 1 | 1.07 | 1.13 | 1.08 | 1.04 | |
| Debt to assets | 0.31 | 0.32 | 0.33 | 0.32 | 0.32 | |
| Net debt to EBITDA | 15.32 | 12.84 | 14.07 | 18.17 | 15.72 | |
| Current ratio | 0.94 | 0.92 | 0.86 | 0.86 | 0.86 | |
| Interest coverage | 4.93 | 5.85 | 4.71 | 5.32 | 4.89 | |
| Income quality | -0.85 | 3.47 | 3.09 | 1.2 | -1.29 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.31 | 0.36 | 0.42 | 0.34 | 0.38 | |
| Sales general and administrative to revenue | 0.11 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.45 | 0.46 | 0.49 | 0.48 | 0.48 | |
| Capex to operating cash flow | 0.35 | -0.13 | -0.1 | -0.2 | 0.35 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.66 | -0.98 | -0.54 | -0.48 | -0.8 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 46.3 | 45.65 | 43.47 | 47.78 | 46.06 | |
| ROIC | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
| Return on tangible assets | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Graham Net | -84.91 | -93.26 | -100.84 | -98.63 | -97.98 | |
| Working capital | -4.05B | -6.35B | -11.45B | -11.41B | -11.33B | |
| Tangible asset value | -31.59B | -38.85B | -48.38B | -46.38B | -43.87B | |
| Net current asset value | -91.28B | -99.04B | -109.31B | -106.65B | -105.23B | |
| Invested capital | 1 | 1.07 | 1.13 | 1.08 | 1.04 | |
| Average receivables | 26.92B | 27.8B | 28.94B | 31.24B | 34.08B | |
| Average payables | 14.38B | 13.68B | 12.95B | 14.12B | 14.89B | |
| Average inventory | 18.57B | 18.68B | 17.78B | 17.62B | 17.99B | |
| Days sales outstanding | 29.28 | 29.9 | 29.9 | 33.01 | 33.8 | |
| Days payables outstanding | 19.07 | 15.68 | 15.97 | 9.51 | 16.77 | |
| Days of inventory on hand | 24.53 | 22.86 | 20.66 | 11.48 | 20.29 | |
| Receivables turnover | 3.07 | 3.01 | 3.01 | 2.73 | 2.66 | |
| Payables turnover | 4.72 | 5.74 | 5.63 | 9.46 | 5.37 | |
| Inventory turnover | 3.67 | 3.94 | 4.36 | 7.84 | 4.43 | |
| ROE | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex per share | -0.53 | -0.77 | -0.46 | -0.42 | -0.71 |
CVS Frequently Asked Questions
What is CVS Health Corporation stock symbol ?
CVS Health Corporation is a US stock , located in Woonsocket of Ri and trading under the symbol CVS
What is CVS Health Corporation stock quote today ?
CVS Health Corporation stock price is $68.9824 today.
Is CVS Health Corporation stock public?
Yes, CVS Health Corporation is a publicly traded company.
Company Profile
- Volume Average 10.31M
- Market Capitalization 86.38B
- Employee 219K
- CEO Ms. Karen Sue Lynch
- Headquarters Woonsocket,RI,US
- IPO Date 1996-11-20
-
Website
https://www.cvshealth.com 
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
